Snook RJ - Search Results

1

A 46-year-old man with dyspnea and left diaphragm paralysis.

Diab K, Snook RJ, Farber M. Diab K, et al. Among authors: snook rj. Chest. 2009 Dec;136(6):1690-1693. doi: 10.1378/chest.09-1072. Chest. 2009. PMID: 19995772 No abstract available.

2

Construct and concurrent validation of the MG-QOL15 in the practice setting.

Burns TM, Grouse CK, Conaway MR, Sanders DB; mg composite and mg-qol15 study group. Burns TM, et al. Muscle Nerve. 2010 Feb;41(2):219-26. doi: 10.1002/mus.21609. Muscle Nerve. 2010. PMID: 19941339

3

Eculizumab improves fatigue in refractory generalized myasthenia gravis.

Andersen H, Mantegazza R, Wang JJ, O'Brien F, Patra K, Howard JF Jr; REGAIN Study Group. Andersen H, et al. Qual Life Res. 2019 Aug;28(8):2247-2254. doi: 10.1007/s11136-019-02148-2. Epub 2019 Mar 23. Qual Life Res. 2019. PMID: 30905021 Free PMC article. Clinical Trial.

4

Carotid artery dissection after trivial trauma in a 13-year-old boy.

Snook R, Sokol DK, Phillips M, Biller J. Snook R, et al. J Stroke Cerebrovasc Dis. 2002 May-Aug;11(3-4):197-200. doi: 10.1053/jscd.2002.129963. J Stroke Cerebrovasc Dis. 2002. PMID: 17903875 No abstract available.

5

Acute painful neuropathy (insulin neuritis) in a boy following rapid glycemic control for type 1 diabetes mellitus.

Wilson JL, Sokol DK, Smith LH, Snook RJ, Waguespack SG, Kincaid JC. Wilson JL, et al. Among authors: snook rj. J Child Neurol. 2003 May;18(5):365-7. doi: 10.1177/08830738030180051701. J Child Neurol. 2003. PMID: 12822825

6

Safety and efficacy of lithium in combination with riluzole for treatment of amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial.

Aggarwal SP, Zinman L, Simpson E, McKinley J, Jackson KE, Pinto H, Kaufman P, Conwit RA, Schoenfeld D, Shefner J, Cudkowicz M; Northeast and Canadian Amyotrophic Lateral Sclerosis consortia. Aggarwal SP, et al. Lancet Neurol. 2010 May;9(5):481-8. doi: 10.1016/S1474-4422(10)70068-5. Epub 2010 Apr 1. Lancet Neurol. 2010. PMID: 20363190 Free PMC article. Clinical Trial.

7

'Minimal symptom expression' in patients with acetylcholine receptor antibody-positive refractory generalized myasthenia gravis treated with eculizumab.

Vissing J, Jacob S, Fujita KP, O'Brien F, Howard JF; REGAIN study group. Vissing J, et al. J Neurol. 2020 Jul;267(7):1991-2001. doi: 10.1007/s00415-020-09770-y. Epub 2020 Mar 18. J Neurol. 2020. PMID: 32189108 Free PMC article. Clinical Trial.

8

Consistent improvement with eculizumab across muscle groups in myasthenia gravis.

Mantegazza R, O'Brien FL, Yountz M, Howard JF Jr; REGAIN study group. Mantegazza R, et al. Ann Clin Transl Neurol. 2020 Aug;7(8):1327-1339. doi: 10.1002/acn3.51121. Epub 2020 Jul 22. Ann Clin Transl Neurol. 2020. PMID: 32700461 Free PMC article. Clinical Trial.

9

Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label Extension.

Mantegazza R, Wolfe GI, Muppidi S, Wiendl H, Fujita KP, O'Brien FL, Booth HDE, Howard JF Jr; REGAIN Study Group. Mantegazza R, et al. Neurology. 2021 Jan 26;96(4):e610-e618. doi: 10.1212/WNL.0000000000011207. Epub 2020 Nov 23. Neurology. 2021. PMID: 33229455 Free PMC article. Clinical Trial.

10

Eculizumab in refractory generalized myasthenia gravis previously treated with rituximab: subgroup analysis of REGAIN and its extension study.

Siddiqi ZA, Nowak RJ, Mozaffar T, O'Brien F, Yountz M, Patti F; REGAIN Study Group. Siddiqi ZA, et al. Muscle Nerve. 2021 Dec;64(6):662-669. doi: 10.1002/mus.27422. Epub 2021 Oct 14. Muscle Nerve. 2021. PMID: 34590717 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

20 results

Search Page

Filters